Inventor · disambiguated record
Ravi V. J. Chari
Also filed as: CHARI RAVI · CHARI RAVI V J · CHARI RAVI VANKEEPURAM JAGANNA
16 granted patents·2,256 citations·filing 1995–2024
96Inventor score
Top patents by PatentIndex Score
16 records- 0199US6534660B1CC-1065 analog synthesisIMMUNOGEN INC·Filed 2002·Granted Mar 18, 2003·168 cites·9 claims
- 0299US6441163B1Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agentsIMMUNOGEN INC·Filed 2001·Granted Aug 27, 2002·690 cites·27 claims
- 0399US6333410B1Process for the preparation and purification of thiol-containing maytansinoidsIMMUNOGEN INC·Filed 2000·Granted Dec 25, 2001·412 cites·34 claims
- 0499US5846545ATargeted delivery of cyclopropylbenzindole-containing cytotoxic drugsIMMUNOGEN INC·Filed 1995·Granted Dec 8, 1998·531 cites·57 claims
- 0598US8163888B2Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugatesSTEEVES RITA M·Filed 2007·Granted Apr 24, 2012·101 cites·53 claims
- 0698US7301019B2Method for the preparation of maytansinoid estersIMMUNOGEN INC·Filed 2006·Granted Nov 27, 2007·41 cites·27 claims
- 0798US6706708B2Cytotoxic agents comprising taxanes and their therapeutic useIMMUNOGEN INC·Filed 2002·Granted Mar 16, 2004·71 cites·12 claims
- 0897US8337856B2Methods of treatment using anti-ERBB antibody-maytansinoid conjugatesBLAETTLER WALTER·Filed 2007·Granted Dec 25, 2012·86 cites·8 claims
- 0997US7411063B2Process for preparation of maytansinolIMMUNOGEN INC·Filed 2006·Granted Aug 12, 2008·31 cites·48 claims
- 1095USRE39151EProcess for the preparation and purification of thiol-containing maytansinoidsIMMUNOGEN INC·Filed 2003·Granted Jun 27, 2006·72 cites·40 claims
- 1193US12066246B2Target residual moisture content for lyophilized drug productREGENERON PHARMA·Filed 2023·Granted Aug 20, 2024·2 cites·20 claims
- 1293US7008942B2Cytotoxic agents comprising taxanes and their therapeutic useIMMUNOGEN INC·Filed 2003·Granted Mar 7, 2006·24 cites·17 claims
- 1392US11525629B2Target residual moisture content for lyophilized drug productREGENERON PHARMA·Filed 2021·Granted Dec 13, 2022·4 cites·20 claims
- 1491US11713922B2Target residual moisture content for lyophilized drug productREGENERON PHARMA·Filed 2022·Granted Aug 1, 2023·3 cites·15 claims
- 1591US7598290B2Cytotoxic agents comprising new C-2 modified taxanesIMMUNOGEN INC·Filed 2007·Granted Oct 6, 2009·20 cites·45 claims
- 1686US12449198B2Target residual moisture content for lyophilized drug productREGENERON PHARMA·Filed 2024·Granted Oct 21, 2025·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Ravi V. J. Chari files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →